Source: https://www.scribd.com/document/157267357/Endotach-Complaint-w-legend-pdf
Timestamp: 2018-12-10 20:01:45
Document Index: 784494091

Matched Legal Cases: ['§ 1331', '§ 1391', '§ 1400', '§ 271', '§ 284', '§ 284', '§ 285']

Endotach-Complaint-w-legend.pdf | Patent Infringement | Lawsuit
Uploaded by Steven Brennan
FEUP Numeros
sometim.pdf
G1_PRA30DO2
Tatatta Ggg
Keep up with tooth fairy tale of two times Written down challenge wake up tothe you doing
CHAMBA SUELOS
Handout Level 1 Module 1
Bencana alam di Indonesia dan penanggulangannya.docx
Case 1:13-cv-01135-JMS-DKL Document 1 Filed 07/16/13 Page 1 of 7 PageID #: 1
IN THE UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION § § § § § § § § §
CIVIL ACTION NO. 1:13-cv-1135 JURY TRIAL DEMANDED
PLAINTIFF’S ORIGINAL COMPLAINT Plaintiff ENDOTACH LLC files this Original Complaint against Defendant COOK MEDICAL INCORPORATED, alleging as follows: I. THE PARTIES 1. Plaintiff ENDOTACH LLC (“Plaintiff”) is a Texas limited liability company with its
principal place of business at 2400 Dallas Parkway, Suite 200, Plano, TX, 75093. 2. Upon information and belief, Defendant COOK MEDICAL INCORPORATED
(“Defendant”) is an Indiana corporation with a principal place of business at 750 Daniels Way, Bloomington, IN 47404. Defendant may be served with process through its registered agent, Corporation Service Company, 251 East Ohio Street, Suite 500, Indianapolis, IN 46204. II. JURISDICTION AND VENUE 3. This is an action for infringement of a United States patent. Federal question
jurisdiction is conferred to this Court over such action under 28 U.S.C. §§ 1331 and 1338(a). 4. Upon information and belief, Defendant is subject to personal jurisdiction by this
Court. Defendant has committed such purposeful acts and/or transactions in the State of Indiana that it reasonably knew and/or expected that it could be haled into an Indiana court as a future
Case 1:13-cv-01135-JMS-DKL Document 1 Filed 07/16/13 Page 2 of 7 PageID #: 2
consequence of such activity. Defendant makes, uses, and/or sells infringing products within the Southern District of Indiana, has a continuing presence within the Southern District of Indiana, and has the requisite minimum contacts with the Southern District of Indiana such that this venue is a fair and reasonable one. Upon information and belief, Defendant has transacted and, at the time of the filing of this Complaint, is continuing to transact business within the Southern District of Indiana. 5. For these reasons, personal jurisdiction exists and venue is proper in this Court under
28 U.S.C. §§ 1391(b) and (c) and 28 U.S.C. § 1400(b). III. PATENTS-IN-SUIT 6. On June 16, 1992, United States Patent No. 5,122,154 (“the ’154 Patent”) was duly
and legally issued to Dr. Valentine J. Rhodes (“Dr. Rhodes”) for an “Endovascular Bypass Graft.” A true and correct copy of the ’154 Patent is attached hereto as Exhibit “A” and made a part hereof. 7. On January 14, 1997, United States Patent No. 5,593,417 (“the ’417 Patent”) was
duly and legally issued to Dr. Rhodes for an “Intravascular Stent with Secure Mounting Means.” A true and correct copy of the ’417 Patent is attached hereto as Exhibit “B” and made a part hereof. 8. The ’154 Patent and the ’417 Patent are sometimes referred to herein collectively as
the “Patents-in-Suit.” 9. As it pertains to this lawsuit, the Patents-in-Suit, generally speaking, relate to an
endovascular graft for revascularization of aneurysms or stenosis occurring in blood vessels that includes anchoring projections to aid in securing the graft in place within the blood vessel. 10. Dr. Rhodes was an award-winning surgeon who practiced in the field of vascular
medicine for over thirty years, serving as Chief of Vascular Services at Point Pleasant Hospital and Brick Hospital (now Ocean Medical Center) in Brick, New Jersey. Dr. Rhodes was prominently
Case 1:13-cv-01135-JMS-DKL Document 1 Filed 07/16/13 Page 3 of 7 PageID #: 3
involved in the field of vascular medicine, demonstrated by several patents related to vascular devices for which he is the named inventor as well as numerous medical publications regarding advances in medical procedures he developed. His innovative work was recognized by the State of New Jersey, which awarded him a certificate of Pioneer in Medicine. 11. During the late 1980s and early 1990s, Dr. Rhodes invented and developed several
improvements in vascular graft technology, including those described in the Patents-in-Suit. In or around 1996, Dr. Rhodes was forced to retire due to a terminal illness. He relocated to Santa Rosa Beach, Florida where he voluntarily treated patients who were without insurance and pursued a number of civic activities, including the establishment of a library in the area. After a prolonged fight with the illness that cost him the entirety of his life savings, Dr. Rhodes passed away in 2000. After his passing, the Patents-in-Suit were devised to a trust created Dr. Rhodes. One of the trustees of this trust, Dr. Rhodes’ wife, Brenda Rhodes (“Mrs. Rhodes”), with consent from other co-trustees, granted Acacia Patent Acquisition LLC (“Acacia”) an exclusive license to the Patents-in-Suit in 2009. Acacia then assigned its rights to the Patents-in-Suit under the exclusive license to Plaintiff. 12. Plaintiff is the owner of all substantial rights in and to the Patents-in-Suit, including
the exclusive right to make, have made, use, import, offer or sell products covered by the Patents-inSuit, to enforce the Patents-in-Suit against all infringers, and to collect past, present and future damages and seek and obtain injunctive or any other relief for infringement of the Patents-in-Suit. III. PROCEDURAL HISTORY 13. This Complaint is being filed out of an abundance of caution. In Endotach LLC v.
Cook Medical Incorporated, Civil Action No. 1:12-cv-01630-LJM-DKL, pending before this Court, Defendant has challenged Plaintiff’s standing to bring that lawsuit by its Motion to Dismiss, which remains pending at this time. In the event the Court were to determine that the 2009 exclusive
Case 1:13-cv-01135-JMS-DKL Document 1 Filed 07/16/13 Page 4 of 7 PageID #: 4
license was insufficient to transfer to Acacia (and consequently Plaintiff) all substantial rights to the Patents-in-Suit, Plaintiff has entered into a corrective amendment to the 2009 exclusive license agreement (effective July 12, 2013) which transfers rights to Plaintiff that Defendant claims Plaintiff does not have. Plaintiff’s intention is to do as much as possible to avoid delay in the progress of its infringement claims against Defendant. To that end, Plaintiff will be seeking consolidation of this action with Civil Action No. 1:12-cv-01630-LJM-DKL. IV. FIRST CLAIM FOR RELIEF (Patent Infringement) 14. 15. Plaintiff repeats and realleges every allegation set forth above. Upon information and belief, and without authority, consent, right, or license, and in
direct infringement of the Patents-in-Suit, Defendant manufactures, makes, has made, uses, markets, sells and/or imports products that infringe one or more claims in the ’154 and ’417 Patents. Such conduct constitutes, at a minimum, patent infringement under 35 U.S.C. § 271(a). 16. Defendant has directly infringed, and continues to infringe, at least claims 1, 14 and
15 of the ’154 Patent by its manufacture, use, sale, offer for sale and/or importation of the Zenith Flex® AAA Endovascular Graft, Zenith® Fenstrated AAA Endovascular Graft, Zenith Renu® AAA Ancillary Graft, and Zenith® TX2® TAA Endovascular Graft. 17. Defendant has directly infringed, and continues to infringe, at least claims 1, 2, and
13 of the ’417 Patent by its manufacture, use, sale, offer for sale and/or importation of the Zenith Flex® AAA Endovascular Graft, Zenith® Fenstrated AAA Endovascular Graft, Zenith Renu® AAA Ancillary Graft, and Zenith® TX2® TAA Endovascular Graft.
Case 1:13-cv-01135-JMS-DKL Document 1 Filed 07/16/13 Page 5 of 7 PageID #: 5
Defendant has knowledge of the Patents-in-Suit at least as early June 21, 2012, the
filing of the Complaint in Endotach LLC v. Cook Medical Incorporated, Civil Action No. 1:12-cv01630-LJM-DKL. 19. Plaintiff has been damaged as a result of Defendant’s infringing conduct. Defendant
is, thus, liable to Plaintiff in an amount that adequately compensates for its infringement, which, by law, cannot be less than a reasonable royalty, together with interest and costs as fixed by this Court under 35 U.S.C. § 284. 20. Upon information and belief, Defendant will continue its infringement of the Patents-
in-Suit unless enjoined by the Court. Defendant’s infringing conducts have caused Plaintiff irreparable harm and will continue to cause such harm without the issuance of an injunction. 21. Plaintiff reserves the right to assert additional claims of the Patents-in-Suit. V. JURY DEMAND Plaintiff hereby requests a trial by jury pursuant to Rule 38 of the Federal Rules of Civil Procedure. VI. PRAYER FOR RELIEF WHEREFORE, Plaintiff respectfully requests that the Court find in its favor and against Defendant, and that the Court grant Plaintiff the following relief: a. Judgment that one or more claims of United States Patent Nos. 5,122,154 and 5,593,417 have been infringed, either literally and/or under the doctrine of equivalents, by Defendant; Judgment that Defendant account for and pay to Plaintiff all damages to and costs incurred by Plaintiff because of Defendant’s infringing activities and other conduct complained of herein; That Defendant’s infringement be found to be willful from the time Defendant became aware of the infringing nature of its services, and that the Court award treble damages for the period of such willful infringement pursuant to 35 U.S.C. § 284.
Case 1:13-cv-01135-JMS-DKL Document 1 Filed 07/16/13 Page 6 of 7 PageID #: 6
That Plaintiff be granted pre-judgment and post-judgment interest on the damages caused by Defendant’s infringing activities and other conduct complained of herein; That the Court declare this an exceptional case and award Plaintiff its reasonable attorney’s fees and costs in accordance with 35 U.S.C. § 285; That Defendant be permanently enjoined from any further activity or conduct that infringes one or more claims of United States Patent Nos. 5,122,154 and 5,593,417; and That Plaintiff be granted such other and further relief as the Court may deem just and proper under the circumstances. Respectfully submitted, /s/ Steven G. Cracraft Indiana Attorney No. 3417-49 BRANNON SOWERS & CRACRAFT PC 1 North Pennsylvania St., Suite 800 Indianapolis, Indiana 46204 Phone: (317) 630-2810 Fax: (317) 630-2813 sgc@bscattorneys.com Jonathan T. Suder (pro hav vice to be filed) TX State Bar No. 19463350 Michael T. Cooke (pro hav vice to be filed) TX State Bar No. 04759650 Brett Pinkus (pro hav vice to be filed) TX State Bar No. 24076625 Glenn S. Orman (pro hav vice to be filed) TX State Bar No. 24074838 FRIEDMAN, SUDER & COOKE Tindall Square Warehouse No. 1 604 East 4th Street, Suite 200 Fort Worth, Texas 76102 Phone: (817) 334-0400 Fax: (817) 334-0401 jts@fsclaw.com mtc@fsclaw.com pinkus@fsclaw.com orman@fsclaw.com
Case 1:13-cv-01135-JMS-DKL Document 1 Filed 07/16/13 Page 7 of 7 PageID #: 7
n:\clients\mj\endotach\cook\pleadings\complaint - cook.doc
Documents Similar To Endotach-Complaint-w-legend.pdf
FISICA INFORME.docxUploaded by Juver Huaripata
Planilha de Ordem de Serviço 4.0 - DeMOUploaded by Daniel Abreu Campos
Analisa Karakteristik Campuran Split Mastic AsphaltUploaded by wahyu
FEUP NumerosUploaded by Carlos Portugal
sometim.pdfUploaded by Tania Hernandez Lopez